These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. Soll AH JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244 [TBL] [Abstract][Full Text] [Related]
9. Optimal management of peptic ulcer disease in the elderly. Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164 [TBL] [Abstract][Full Text] [Related]
11. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708 [TBL] [Abstract][Full Text] [Related]
12. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease. Tytgat GN Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941 [TBL] [Abstract][Full Text] [Related]
13. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
14. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235 [TBL] [Abstract][Full Text] [Related]
15. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE Cochrane Database Syst Rev; 2003; (4):CD004062. PubMed ID: 14584003 [TBL] [Abstract][Full Text] [Related]
17. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease. Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725 [TBL] [Abstract][Full Text] [Related]
19. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. Lanas A; Remacha B; Sáinz R; Hirschowitz BI Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760 [TBL] [Abstract][Full Text] [Related]
20. Peptic ulcer disease. Smoot DT; Go MF; Cryer B Prim Care; 2001 Sep; 28(3):487-503, v. PubMed ID: 11483440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]